Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
| ▸ | LIPE | Q05469 | 5/20 | 0.41 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8989513 | 0.79 | KMT2A (0.56) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL30980818 | 0.79 | TSHR (0.63) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL706406 | 0.79 | KMT2A (0.51) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL706407 | 0.79 | TSHR (0.63) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL19956152 | 0.79 | KMT2A (0.51) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL11351938 | 0.78 | MAPT (0.69) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL20381743 | 0.77 | HPGD (0.48) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL5080403 | 0.77 | MRGPRX4 (0.48) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL1995774 | 0.76 | HPGD (0.50) | KMT2ATSHRSMN1; SMN2HPGDTHRB | |
| SCHEMBL2737128 | 0.76 | TSHR (0.51) | KMT2ATSHRSMN1; SMN2HPGDTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10702507-B2 | Endoparasite control agent | THE UNIVERSITY OF TOKYO (JP) | 2020-07-07 | — | — | US | disclosed |
| US-20190046511-A1 | ENDOPARASITE CONTROL AGENT | THE UNIVERSITY OF TOKYO (JP) | 2019-02-14 | — | — | US | disclosed |
| WO-2007072201-A2 | 3-AMINOCYCLOPENTANECARBOXAMIDES AS MODULATORS OF CHEMOKINE RECEPTORS | INCYTE CORPORATION (US) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190046511-A1 | ENDOPARASITE CONTROL AGENT | NAAA, CTRL, ENPP1 | KMT2A 272/4885TSHR 4137/4885SMN1; SMN2 4395/4885 |
| US-10702507-B2 | Endoparasite control agent | NAAA, CTRL, ENPP1 | KMT2A 272/4885TSHR 4137/4885SMN1; SMN2 4395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.